Close Menu

In light of the ACLU versus Myriad Genetics case, David Ewing Duncan at Tech Review asks the age-old question: "Should human DNA be owned?" In the US, Duncan says that an individual's BRCA1 gene cannot be patented, but that Myriad could patent a mutated gene sequence associated with breast cancer. Then, patients' genes could be compared to the patented sequence -- that is what the ACLU and other plaintiffs say is a mistake. Duncan says the complaint is beside the point.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Researchers have developed a robotic lab assistant, the Verge reports.

CBC News reports Canada's Supreme Court is to rule on the constitutionality of the country's genetic non-discrimination law today.

The Associated Press reports the World Health Organization is sending experts to China to investigate the animal source of SARS-CoV-2.

In Science this week: atlas of affected cell populations in idiopathic pulmonary fibrosis, and more.